Herbal Medicine Dihydroartemisinin Inhibits Colorectal Cancer by Regulating PI3K/AKT Signaling Pathway

Abstract

Colorectal cancer (CRC) is the third most prevalent digestive tract cancer worldwide (9.7%), with a severe morbidity and mortality rate. The major therapeutic medications for CRC today are chemotherapy and targeted monoclonal antibodies, however, they all have drawbacks such as high cost, drug resistance, and substantial immunological adverse effects, and not all patients can benefit from them.